185 related articles for article (PubMed ID: 20050660)
1. Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines.
Stone EM; Glazer ES; Chantranupong L; Cherukuri P; Breece RM; Tierney DL; Curley SA; Iverson BL; Georgiou G
ACS Chem Biol; 2010 Mar; 5(3):333-42. PubMed ID: 20050660
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of complexes with cobalt-reconstituted human arginase I.
D'Antonio EL; Christianson DW
Biochemistry; 2011 Sep; 50(37):8018-27. PubMed ID: 21870783
[TBL] [Abstract][Full Text] [Related]
3. A bioengineered arginine-depleting enzyme as a long-lasting therapeutic agent against cancer.
Chung SF; Kim CF; Tam SY; Choi MC; So PK; Wong KY; Leung YC; Lo WH
Appl Microbiol Biotechnol; 2020 May; 104(9):3921-3934. PubMed ID: 32144472
[TBL] [Abstract][Full Text] [Related]
4. Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy.
Stone E; Chantranupong L; Gonzalez C; O'Neal J; Rani M; VanDenBerg C; Georgiou G
J Control Release; 2012 Feb; 158(1):171-9. PubMed ID: 22001609
[TBL] [Abstract][Full Text] [Related]
5. Metal ions-induced stability and function of bimetallic human arginase-I, a therapeutically important enzyme.
Sadarangani V; Rahman S; Sau AK
Biochim Biophys Acta Proteins Proteom; 2018 Nov; 1866(11):1153-1164. PubMed ID: 30282613
[TBL] [Abstract][Full Text] [Related]
6. Role of a disulphide bond in Helicobacter pylori arginase.
Srivastava A; Dwivedi N; Sau AK
Biochem Biophys Res Commun; 2010 May; 395(3):348-51. PubMed ID: 20381458
[TBL] [Abstract][Full Text] [Related]
7. Biochemical studies on Helicobacter pylori arginase: insight into the difference in activity compared to other arginases.
Srivastava A; Sau AK
IUBMB Life; 2010 Dec; 62(12):906-15. PubMed ID: 21190293
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Bacillus anthracis arginase: effects of pH, temperature, and cell viability on metal preference.
Viator RJ; Rest RF; Hildebrandt E; McGee DJ
BMC Biochem; 2008 Jun; 9():15. PubMed ID: 18522738
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily.
McGee DJ; Zabaleta J; Viator RJ; Testerman TL; Ochoa AC; Mendz GL
Eur J Biochem; 2004 May; 271(10):1952-62. PubMed ID: 15128304
[TBL] [Abstract][Full Text] [Related]
10. Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthetase-1.
Glazer ES; Kaluarachchi WD; Massey KL; Zhu C; Curley SA
Surgery; 2010 Aug; 148(2):310-8. PubMed ID: 20466402
[TBL] [Abstract][Full Text] [Related]
11. Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma.
Cheng PN; Leung YC; Lo WH; Tsui SM; Lam KC
Cancer Lett; 2005 Jun; 224(1):67-80. PubMed ID: 15911102
[TBL] [Abstract][Full Text] [Related]
12. Studies on the advent of ureotelism. The effects of bivalent cations on the capacity of the hepatic arginase of the Mexican axolotl to hydrolyse endogenous arginine.
Palacios R; Huitrón C; Soberón G
Biochem J; 1969 Sep; 114(3):449-54. PubMed ID: 5820633
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.
Lam TL; Wong GK; Chong HC; Cheng PN; Choi SC; Chow TL; Kwok SY; Poon RT; Wheatley DN; Lo WH; Leung YC
Cancer Lett; 2009 May; 277(1):91-100. PubMed ID: 19138817
[TBL] [Abstract][Full Text] [Related]
14. Insights into the interaction of human liver arginase with tightly and weakly bound manganese ions by chemical modification and site-directed mutagenesis studies.
Orellana MS; López V; Uribe E; Fuentes M; Salas M; Carvajal N
Arch Biochem Biophys; 2002 Jul; 403(2):155-9. PubMed ID: 12139964
[TBL] [Abstract][Full Text] [Related]
15. L-arginine binding to liver arginase requires proton transfer to gateway residue His141 and coordination of the guanidinium group to the dimanganese(II,II) center.
Khangulov SV; Sossong TM; Ash DE; Dismukes GC
Biochemistry; 1998 Jun; 37(23):8539-50. PubMed ID: 9622506
[TBL] [Abstract][Full Text] [Related]
16. Altering the binuclear manganese cluster of arginase diminishes thermostability and catalytic function.
Scolnick LR; Kanyo ZF; Cavalli RC; Ash DE; Christianson DW
Biochemistry; 1997 Aug; 36(34):10558-65. PubMed ID: 9265637
[TBL] [Abstract][Full Text] [Related]
17. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
[TBL] [Abstract][Full Text] [Related]
18. Highly selective apo-arginase based method for sensitive enzymatic assay of manganese (II) and cobalt (II) ions.
Stasyuk N; Gayda G; Zakalskiy A; Zakalska O; Errachid A; Gonchar M
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Mar; 193():349-356. PubMed ID: 29268235
[TBL] [Abstract][Full Text] [Related]
19. Arginine deprivation in cancer therapy.
Feun LG; Kuo MT; Savaraj N
Curr Opin Clin Nutr Metab Care; 2015 Jan; 18(1):78-82. PubMed ID: 25474015
[TBL] [Abstract][Full Text] [Related]
20. Cloning, expression, and characterization of a thermostable l-arginase from Geobacillus thermodenitrificans NG80-2 for l-ornithine production.
Huang K; Mu W; Zhang T; Jiang B; Miao M
Biotechnol Appl Biochem; 2016 May; 63(3):391-7. PubMed ID: 25908562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
